Literature DB >> 17594680

Cluster without fluster: The effect of correlated outcomes on inference in randomized clinical trials.

Michael Proschan1, Dean Follmann.   

Abstract

Inference for randomized clinical trials is generally based on the assumption that outcomes are independently and identically distributed under the null hypothesis. In some trials, particularly in infectious disease, outcomes may be correlated. This may be known in advance (e.g. allowing randomization of family members) or completely unplanned (e.g. sexual sharing among randomized participants). There is particular concern when the form of the correlation is essentially unknown, in which case we cannot take advantage of the correlation to construct a more efficient test. Instead, we can only investigate the impact of potential correlation on the independent-samples test statistic. Randomization tends to balance out treatment and control assignments within clusters, so it is logical that performance of tests averaged over all possible randomization assignments would be essentially unaffected by arbitrary correlation. We confirm this intuition by showing that a permutation test controls the type 1 error rate in a certain average sense whenever the clustering is independent of treatment assignment. It is nonetheless possible to obtain a 'bad' randomization such that members of a cluster tend to be assigned to the same treatment. Conditioned on such a bad randomization, the type 1 error rate is increased.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17594680     DOI: 10.1002/sim.2977

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Moderators of two indicated cognitive-behavioral depression prevention approaches for adolescents in a school-based effectiveness trial.

Authors:  Frédéric N Brière; Paul Rohde; Heather Shaw; Eric Stice
Journal:  Behav Res Ther       Date:  2013-12-27

2.  On the design and analysis of clinical trials with correlated outcomes.

Authors:  Dean Follmann; Michael Proschan
Journal:  Contemp Clin Trials       Date:  2014-08-08       Impact factor: 2.226

3.  Analytic methods for individually randomized group treatment trials and group-randomized trials when subjects belong to multiple groups.

Authors:  Rebecca R Andridge; Abigail B Shoben; Keith E Muller; David M Murray
Journal:  Stat Med       Date:  2014-01-08       Impact factor: 2.373

4.  Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules.

Authors:  Michael P Fay; Michael A Proschan
Journal:  Stat Surv       Date:  2010

5.  Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.

Authors:  Joshua N Sampson; Allan Hildesheim; Rolando Herrero; Paula Gonzalez; Aimee R Kreimer; Mitchell H Gail
Journal:  Contemp Clin Trials       Date:  2018-02-21       Impact factor: 2.226

6.  Assessing potential sources of clustering in individually randomised trials.

Authors:  Brennan C Kahan; Tim P Morris
Journal:  BMC Med Res Methodol       Date:  2013-04-16       Impact factor: 4.615

7.  Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?

Authors:  Brennan C Kahan
Journal:  BMC Med Res Methodol       Date:  2014-02-10       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.